Briukhovetska, D., Suarez-Gosalvez, J., Voigt, C., Markota, A., Giannou, A. D., Schübel, M., . . . Kobold, S. (2023). T cell-derived interleukin-22 drives the expression of CD155 by cancer cells to suppress NK cell function and promote metastasis.
Chicago Style CitationBriukhovetska, Daria, et al. T Cell-derived Interleukin-22 Drives the Expression of CD155 By Cancer Cells to Suppress NK Cell Function and Promote Metastasis. 2023.
MLA CitationBriukhovetska, Daria, et al. T Cell-derived Interleukin-22 Drives the Expression of CD155 By Cancer Cells to Suppress NK Cell Function and Promote Metastasis. 2023.
Warning: These citations may not always be 100% accurate.